packageLenvatinib

lenvatinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Lenvatinib is a protein kinase inhibitor used to treat certain cancers, including thyroid cancer and kidney (renal cell) cancer. It is authorised in the European Union and is used in cancer care.

Summary written by glm-5.3-flash from Wikidata Q6523413 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:lenvatinib
ATC codes:L01EX08, L01XE, L01XE29
DrugBank:DB09078
PubChem CID:9823820
ChEBI:85994
Wikidata:Q6523413
formula:C21H19ClN4O4
molar mass:426.857 g/mol (PubChem CID 9823820)
logP:2.8 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown